Valued at USD 81.96 billion in 2024, the Specialty Generic Drugs Market is projected to grow from USD 89.55 billion in 2025 to USD 202.66 billion by 2034, exhibiting a CAGR of 9.5% during 2025–2034. North America held the largest share in 2024. Specialty generics provide cost-effective alternatives to branded complex products for oncology, autoimmune, and rare conditions. The oncology...